Current status of advance care planning, palliative care consultation, and end-of-life care in patients with glioblastoma in South Korea
Aktueller Stand von Advance Care Planning, Palliativversorgung und End-of-Life-Care bei Patient:innen mit Glioblastom in Südkorea
The Oncologist · 04.11.2024 · 29 (11) · e1586-e1592
DOI: 10.1093/oncolo/oyae159 ↗Auf einen Blick
Bei 159 verstorbenen Patient:innen mit Glioblastom waren Advance Directives und Pläne zu lebenserhaltenden Maßnahmen selten selbst verfasst. Palliativversorgung war mit weniger aggressiver End-of-Life-Care verbunden.
Fragestellung
Wie häufig sind ACP, Palliativversorgung und End-of-Life-Care bei Patient:innen mit Glioblastom umgesetzt, und wie hängt Palliativkonsultation mit der Intensität der End-of-Life-Care zusammen?
Methode
Kohortenstudie an 205 Patient:innen eines koreanischen tertiären Krankenhauses; Erhebung von ACP, LST-Plänen, Palliativkonsultation und Aggressivität der End-of-Life-Care.
Ergebnisse
159 Patient:innen starben; medianes Gesamtüberleben 20,3 Monate. 11 (6,9 %) hatten eine AD, 63 (39,6 %) einen LST-Plan, 85 (53,5 %) keines von beidem. Palliativkonsultation: 102 (64,2 %); aggressive EOL-Care: 78 (49,1 %).
Schlussfolgerung der Autor:innen
Das Recht auf Selbstbestimmung war bei Patient:innen mit Glioblastom unzureichend geschützt. Palliativkonsultation war mit weniger aggressiver End-of-Life-Care und längerer Hospiznutzung verbunden.
Kernaussagen
- AD: 6,9 %; LST-Plan: 39,6 %; 53,5 % weder noch
- Palliativkonsultation bei 64,2 % der Verstorbenen
- Mit Palliativkonsultation: weniger aggressive EOL-Care
Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.
Kurz gefasst
Fachartikel in der Zeitschrift The Oncologist, online erschienen am 28.06.2024. Verfasst von Koung Jin Suh und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Seoul National University College of Medicine, Seoul National University Bundang Hospital, Seongnam, Korea. Hauptthemen laut MEDLINE: Advance Care Planning, Terminal Care, Palliative Care, Glioblastoma. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Themen: Ethik in der Pflege, Palliativpflege
Abstract (Originalsprache)
Background
Given the typical trajectory of glioblastoma, many patients lose decision-making capacity over time, which can lead to inadequate advance care planning (ACP) and end-of-life (EOL) care. We aimed to evaluate patients’ current ACP and EOL care status. Patients and Methods We conducted a cohort study on 205 patients referred to oncologists at a Korean tertiary hospital between 2017 and 2022. We collected information on sociodemographic factors, cancer treatment, palliative care consultation, ACP, legal documents on life-sustaining treatment (LST) decisions, and aggressiveness of EOL care.
Results
With a median follow-up time of 18.3 months: 159 patients died; median overall survival: 20.3 months. Of the 159 patients, 11 (6.9%) and 63 (39.6%) had advance directive (AD) and LST plans, respectively, whereas 85 (53.5%) had neither. Among the 63 with LST plans, 10 (15.9%) and 53 (84.1%) completed their forms through self-determination and family determination, respectively. Of the 159 patients who died, 102 (64.2%) received palliative care consultation (median time: 44 days from the first consultation to death) and 78 (49.1%) received aggressive EOL care. Those receiving palliative care consultations were less likely to receive aggressive EOL care (83.3% vs 32.4%, P < .001), and more likely to use more than 3 days of hospice care at EOL (19.6% vs 68.0%, P < .001).
Conclusions
The right to self-determination remains poorly protected among patients with glioblastoma, with nearly 90% not self-completing AD or LST plan. As palliative care consultation is associated with less aggressive EOL care and longer use of hospice care, physicians should promptly introduce patients to ACP conversations and palliative care consultations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Internal Medicine, Seoul National University College of Medicine, Seoul National University Bundang Hospital, Seongnam, Korea.
- Department of Neurosurgery, Seoul National University College of Medicine, Seoul National University Bundang Hospital, Seongnam, Korea.
- Department. of Radiation Oncology, Seoul National University College of Medicine, Seoul National University Bundang Hospital, Seongnam, Korea.
ORCID-Profile: Yu Jung Kim
Zitieren
APA
Suh, K. J., Jung, E. H., Seo, J., Ji, S. Y., Hwang, K., Han, J. H., Kim, C. Y., Kim, I. A., & Kim, Y. J. (2024). Current status of advance care planning, palliative care consultation, and end-of-life care in patients with glioblastoma in South Korea. The Oncologist, 29(11), e1586-e1592. https://doi.org/10.1093/oncolo/oyae159
Vancouver
Suh KJ, Jung EH, Seo J, Ji SY, Hwang K, Han JH, et al. Current status of advance care planning, palliative care consultation, and end-of-life care in patients with glioblastoma in South Korea. The Oncologist. 2024;29(11):e1586-e1592. doi:10.1093/oncolo/oyae159
BibTeX
@article{Suh2024,
author = {Suh, Koung Jin and Jung, Eun Hee and Seo, Jeongmin and Ji, So Young and Hwang, Kihwan and Han, Jung Ho and Kim, Chae-Yong and Kim, In Ah and Kim, Yu Jung},
title = {Current status of advance care planning, palliative care consultation, and end-of-life care in patients with glioblastoma in South Korea},
journal = {The Oncologist},
year = {2024},
volume = {29},
number = {11},
pages = {e1586--e1592},
doi = {10.1093/oncolo/oyae159}
}
EUVIMED